Parallel Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.19K | Sell |
551
-32
| -5% | -$287 | ﹤0.01% | 3200 |
|
|
2026
Q1 | $4.75K | Sell |
583
-100
| -15% | -$906 | ﹤0.01% | 3046 |
|
|
2025
Q4 | $4.59K | Buy |
683
+32
| +5% | +$241 | ﹤0.01% | 2877 |
|
|
2025
Q3 | $5.64K | Sell |
651
-382
| -37% | -$2.97K | ﹤0.01% | 2735 |
|
|
2025
Q2 | $6.51K | Buy |
1,033
+639
| +162% | +$4.23K | ﹤0.01% | 2646 |
|
|
2025
Q1 | $2.53K | Sell |
394
-103
| -21% | -$851 | ﹤0.01% | 2904 |
|
|
2024
Q4 | $4K | Buy |
497
+69
| +16% | +$665 | ﹤0.01% | 2718 |
|
|
2024
Q3 | $5.41K | Sell |
428
-1
| -0.2% | -$13 | ﹤0.01% | 2585 |
|
|
2024
Q2 | $5.43K | Buy |
+429
| New | +$4.32K | ﹤0.01% | 2515 |
|
|
2023
Q4 | – | Sell |
-54
| Closed | -$391 | – | 3422 |
|
|
2023
Q3 | $391 | Sell |
54
-1,036
| -95% | -$8.28K | ﹤0.01% | 3150 |
|
|
2023
Q2 | $8.1K | Buy |
1,090
+865
| +384% | +$6.8K | ﹤0.01% | 2255 |
|
|
2023
Q1 | $1.56K | Sell |
225
-397
| -64% | -$3.65K | ﹤0.01% | 2840 |
|
|
2022
Q4 | $6.39K | Buy |
622
+469
| +307% | +$8.28K | ﹤0.01% | 2218 |
|
|
2022
Q3 | $3K | Buy |
153
+39
| +34% | +$1.69K | ﹤0.01% | 2505 |
|
|
2022
Q2 | $6K | Buy |
114
+57
| +100% | +$2.95K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $4K | Sell |
57
-88
| -61% | -$7.85K | ﹤0.01% | 2388 |
|
|
2021
Q4 | $21K | Sell |
145
-24
| -14% | -$4.12K | ﹤0.01% | 1753 |
|
|
2021
Q3 | $35K | Buy |
169
+106
| +168% | +$23.4K | ﹤0.01% | 1457 |
|
|
2021
Q2 | $13K | Buy |
63
+24
| +62% | +$4.4K | ﹤0.01% | 1903 |
|
|
2021
Q1 | $7K | Buy |
39
+34
| +680% | +$6.78K | ﹤0.01% | 2077 |
|
|
2020
Q4 | $1K | Sell |
5
-231
| -98% | -$24.6K | ﹤0.01% | 2458 |
|
|
2020
Q3 | $26K | Hold |
236
| – | – | ﹤0.01% | 1336 |
|
|
2020
Q2 | $19K | Hold |
236
| – | – | ﹤0.01% | 1436 |
|
|
2020
Q1 | $3K | Buy |
+236
| New | +$2K | ﹤0.01% | 2041 |
|
|
2017
Q4 | – | Sell |
-10
| Closed | – | – | 2118 |
|
|
2017
Q3 | $0 | Sell |
10
-15
| -60% | -$336 | ﹤0.01% | 2180 |
|
|
2017
Q2 | $1K | Sell |
25
-32
| -56% | -$628 | ﹤0.01% | 2004 |
|
|
2017
Q1 | $1K | Buy |
57
+10
| +21% | +$275 | ﹤0.01% | 1902 |
|
|
2016
Q4 | $1K | Buy |
+47
| New | +$1.37K | ﹤0.01% | 1718 |
|
Other funds holding NVAX
SCM
S
Parallel Advisors's NVAX Position: Q2 2026 in Review
Parallel Advisors reduced its Novavax (NVAX) stake by 5.5% in Q2 2026, selling an estimated $287 and leaving 551 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.
Parallel Advisors first reported a position in NVAX in Q4 2016 and has held it in 28 quarters since. The position peaked at $35K in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Parallel Advisors held 551 shares of Novavax worth $5.19K as of Q2 2026.
- Parallel Advisors sold 32 Novavax shares in Q2 2026, an estimated $287.
- Novavax made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3200 holding.
- Parallel Advisors first reported a position in Novavax in Q4 2016 and has held it in 28 quarters since.
- Parallel Advisors's Novavax position peaked at $35K in Q3 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.